References
- Norsk selskap for allmennmedisin. Sju teser for allmenn-medisin. En oppsummering av NSAM's tenkedugnad 2000–2001 [available at: http://www.uib.nofisfinsam].
- William DDR, Garner J. The case against "the evidence": a different perspective on evidence-based medicine. Br J Psychiatry 2002;180:8–12.
- En komite oppnevnt av Alment praktiserende lwgers foren-ing, Norsk selskap for allmennmedisin, Offentlige legers landsforening, Norsk bedriftslegeforening. Primwrlegen mot dr 2000. Oslo, 1991.
- Thoresen SO, Skare GB, Sandvin O. Masseundersokelser for livmorhalskreft (Mass screening for cervical cancer. Experi-ences after 25 years of voluntary and 2 years of organized screening). Tidsskr Nor Lwgeforen 1997;117: 2613–5.
- Smith R. In search of "non-disease". BMJ 2002;324:883–5.
- Moller Nielsen J, Dehlholm-Lambertsen B, Maunsbach ME, Olesen F. Sygdomsopfattelser i almen praksis - i relation til patienter med somatiseriende lidelse (Illness perception in general practice - in relation to patients with somatization disorders). Ugeskr Lwger 2002;164:5372–6.
- Salmon P, Peters S, Stanley I. Patients' perceptions of medical explanations for somatisation disorders: qualitative analysis. BMJ 1999;318:372–6.
- Reventlow S, Hvas AC, Tulinius C. "In really great danger..." The concept of risk in general practice. Scand J Prim Health Care 2001;19:71–5.
- Getz L, Kirkengen AL. Ultrasound screening in pregnancy: Advancing technology, soft markers for fetal chromosomal aberrations, and unacknowledged ethical dilemmas. Sos Sci Med 2003;56:2045–57.
- Skolbekken JA. The risk epidemic in medical journals. Soc Sci Med 1995;40:291–305.
- Marok E. Om helsens skjulte natur (The hidden nature of health). Tidsskr Nor Lwgeforen 2001;121:1610–2.
- Getz L, Nilsson PM, Hetlevik I. A matter of heart: The general practitioner consultation in an evidence-based world. Scand J Prim Health Care 2003;21:3–9.
- Hollnagel H, Malterud K. From risk factors to health resources in medical practice. Med Health Care Philos 2000;3:257–64.
- Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry and disease mongering. BMJ 2002;324:889–91.
- Kirkengen AL. Inscribed bodies. Health impact of child-hood sexual abuse. Dordrecht: Kluwer, 2001.
- Buajordet I, Ebbesen J, Erikssen J, Buffs O, Hilberg T. Fatal adverse drug events: The paradox of drug treatment. J Intern Med 2001;250:327–41.
- Fretheim A, Bjorndal A, Oxman AD, Dyrdal A, Golding M, Ose L, et al. Hvilke blodtrykkssenkende legemidler bor brukes for primwrforebygging av hjerte- og karsykdommer? (Which antihypertensive drugs should be used in the primary prevention of cardiovascular disease?). Tidsskr Nor Lwgeforen 2002;122:2283–6.
- Fretheim A, Bjorndal A, Oxman AD, Dyrdal A, Golding M, Ose L, et al. Hvilke kolesterolsenkende legemidler bor brukes for primwrforebygging av hjerte- og karsykdommer? (Which cholesterol-lowering drugs should be used in the primary prevention of cardiovascular diseases?). Tidsskr Nor Lwgeforen 2002;122:2287–8.
- Hetlevik I. The role of clinical guidelines in cardiovascular risk intervention in general practice (dissertation). Trond-heim: Department of Community Medicine and General Practice, NTNU, Bjaerum, 1999.
- Getz L, Sigurdsson JA, Hetlevik I. Is opportunistic disease prevention in the consultation ethically justifiable? BMJ 2003;327:498–500.
- Nessa J. Si scientia, unde malum? Eit essay om risiko. In: Swensen E, editor. Diagnose: Risiko. Oslo: Universitetsfor-laget, 2000.
- Lie AK. Mellom preken og Stand Up. Om noen problemer med a bringe samfunnet til sykesengen. In: Bjorndal A, Nylenna M, editors. Med makten i sitt ord. Oslo: Unipub forlag, 2003.
- Moynihan R, Smith R (editorial). Too much medicine? Almost certainly. BMJ 2002;324:859–60.
- Getz L. Fragmentenes forvaltere (Managers of fragments). Tidsskr Nor Lwgeforen 2001;121:1562.